These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23802699)

  • 21. Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne.
    Webster GF
    J Drugs Dermatol; 2011 Jun; 10(6):636-44. PubMed ID: 21637904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical retinoid and antibiotic combination therapy for acne management.
    Weiss JS; Shavin JS
    J Drugs Dermatol; 2004; 3(2):146-54. PubMed ID: 15098969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study.
    Barbieri JS; Hoffstad O; Margolis DJ
    J Am Acad Dermatol; 2016 Dec; 75(6):1142-1150.e1. PubMed ID: 27502311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Topical Retinoid for Acne: Trifarotene 50 μg/g Cream.
    Tan J; Miklas M
    Skin Therapy Lett; 2020 Mar; 25(2):1-2. PubMed ID: 32196146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship of Proper Skin Cleansing to Pathophysiology, Clinical Benefits, and the Concomitant Use of Prescription Topical Therapies in Patients with Acne Vulgaris.
    Levin J
    Dermatol Clin; 2016 Apr; 34(2):133-45. PubMed ID: 27015773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the treatment of acne vulgaris with topical retinoids.
    Hsu P; Litman GI; Brodell RT
    Postgrad Med; 2011 May; 123(3):153-61. PubMed ID: 21566426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical retinoids in the treatment of acne vulgaris.
    Zaenglein AL
    Semin Cutan Med Surg; 2008 Sep; 27(3):177-82. PubMed ID: 18786495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.
    Harper J
    Manag Care Interface; 2005 Mar; 18(3):51-5. PubMed ID: 15816299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M; Nakagawa T; Fukamachi K; Nakamura M; Tokura Y
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of preadolescent acne in the United States: an analysis of nationally representative data.
    Davis SA; Sandoval LF; Gustafson CJ; Feldman SR; Cordoro KM
    Pediatr Dermatol; 2013; 30(6):689-94. PubMed ID: 23876222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical acne drugs: review of clinical properties, systemic exposure, and safety.
    Akhavan A; Bershad S
    Am J Clin Dermatol; 2003; 4(7):473-92. PubMed ID: 12814337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trifarotene: First Approval.
    Scott LJ
    Drugs; 2019 Nov; 79(17):1905-1909. PubMed ID: 31713811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tazarotene foam, 0.1%, for the treatment of acne.
    Smith JA; Narahari S; Hill D; Feldman SR
    Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case-based experience with the simultaneous use of a fixed topical antibiotic/benzoyl peroxide combination and a topical retinoid in the optimization of acne management.
    Ditre CM
    J Drugs Dermatol; 2009 Dec; 8(12):1127-31. PubMed ID: 20027941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for the development of new topical treatments for acne vulgaris.
    Gibson JR
    Cutis; 1996 Jan; 57(1 Suppl):13-9. PubMed ID: 8654127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical considerations in acne treatment and the clinical impact of topical combination therapy.
    Krakowski AC; Stendardo S; Eichenfield LF
    Pediatr Dermatol; 2008 Jun; 25 Suppl 1():1-14. PubMed ID: 18494684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne.
    Veraldi S; Giovene GL; Guerriero C; Bettoli V
    G Ital Dermatol Venereol; 2012 Oct; 147(5):491-7. PubMed ID: 23007255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing the face of acne therapy.
    Ghali F; Kang S; Leyden J; Shalita AR; Thiboutot DM
    Cutis; 2009 Feb; 83(2 Suppl):4-15. PubMed ID: 19363873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spironolactone and topical retinoids in adult female cyclical acne.
    Lessner E; Fisher S; Kobraei K; Osleber M; Lessner R; Elliott L; Wesson S
    J Drugs Dermatol; 2014 Feb; 13(2):126-9. PubMed ID: 24509960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical antibiotic monotherapy prescribing practices in acne vulgaris.
    Hoover WD; Davis SA; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2014 Apr; 25(2):97-9. PubMed ID: 24171409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.